These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8075887)

  • 1. Importance of the intestine as a site of metformin-stimulated glucose utilization.
    Bailey CJ; Mynett KJ; Page T
    Br J Pharmacol; 1994 Jun; 112(2):671-5. PubMed ID: 8075887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of metformin on glucose metabolism in the splanchnic bed.
    Bailey CJ; Wilcock C; Day C
    Br J Pharmacol; 1992 Apr; 105(4):1009-13. PubMed ID: 1504710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine.
    Pénicaud L; Hitier Y; Ferré P; Girard J
    Biochem J; 1989 Sep; 262(3):881-5. PubMed ID: 2686622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin requirement for the antihyperglycaemic effect of metformin.
    Bailey CJ; Mynett KJ
    Br J Pharmacol; 1994 Mar; 111(3):793-6. PubMed ID: 7912625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endotoxin-induced increases in regional glucose utilization by small intestine: a TNF-independent effect.
    Lang CH; Obih JA; Bagby GJ; Bagwell JN; Spitzer JJ
    Am J Physiol; 1991 Apr; 260(4 Pt 1):G548-55. PubMed ID: 2018131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of metformin on the vascular and glucose metabolic actions of insulin in hypertensive rats.
    Santuré M; Pitre M; Gaudreault N; Marette A; Nadeau A; Bachelard H
    Am J Physiol Gastrointest Liver Physiol; 2000 May; 278(5):G682-92. PubMed ID: 10801260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
    Yoshida T; Okuno A; Tanaka J; Takahashi K; Nakashima R; Kanda S; Ogawa J; Hagisawa Y; Fujiwara T
    Eur J Pharmacol; 2009 Nov; 623(1-3):141-7. PubMed ID: 19765581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose utilization is suppressed in the gut of insulin-resistant high fat-fed rats and is restored by metformin.
    Mithieux G; Rajas F; Zitoun C
    Biochem Pharmacol; 2006 Jul; 72(2):198-203. PubMed ID: 16737687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of insulin on regional blood flow and glucose uptake in Wistar and Sprague-Dawley rats.
    Gaudreault N; Santuré M; Pitre M; Nadeau A; Marette A; Bachelard H
    Metabolism; 2001 Jan; 50(1):65-73. PubMed ID: 11172477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin-induced regulation of the intestinal D-glucose transporters.
    Sakar Y; Meddah B; Faouzi MA; Cherrah Y; Bado A; Ducroc R
    J Physiol Pharmacol; 2010 Jun; 61(3):301-7. PubMed ID: 20610860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased glucose uptake by intestinal mucosa and muscularis in hypermetabolic sepsis.
    Lang CH; Obih JC; Bagby GJ; Bagwell JN; Spitzer JJ
    Am J Physiol; 1991 Aug; 261(2 Pt 1):G287-94. PubMed ID: 1678586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconsideration of inhibitory effect of metformin on intestinal glucose absorption.
    Wilcock C; Bailey CJ
    J Pharm Pharmacol; 1991 Feb; 43(2):120-1. PubMed ID: 1672896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin treatment significantly enhances intestinal glucose uptake in patients with type 2 diabetes: Results from a randomized clinical trial.
    Koffert JP; Mikkola K; Virtanen KA; Andersson AD; Faxius L; Hällsten K; Heglind M; Guiducci L; Pham T; Silvola JMU; Virta J; Eriksson O; Kauhanen SP; Saraste A; Enerbäck S; Iozzo P; Parkkola R; Gomez MF; Nuutila P
    Diabetes Res Clin Pract; 2017 Sep; 131():208-216. PubMed ID: 28778047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine.
    Ikeda T; Iwata K; Murakami H
    Biochem Pharmacol; 2000 Apr; 59(7):887-90. PubMed ID: 10718348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells.
    Hundal HS; Ramlal T; Reyes R; Leiter LA; Klip A
    Endocrinology; 1992 Sep; 131(3):1165-73. PubMed ID: 1505458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin.
    Sarabia V; Lam L; Burdett E; Leiter LA; Klip A
    J Clin Invest; 1992 Oct; 90(4):1386-95. PubMed ID: 1401073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and Systemic Metabolism.
    He L
    Trends Pharmacol Sci; 2020 Nov; 41(11):868-881. PubMed ID: 32994049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of metformin treatment on glucose transporter proteins in subcellular fractions of skeletal muscle in (fa/fa) Zucker rats.
    Rouru J; Koulu M; Peltonen J; Santti E; Hänninen V; Pesonen U; Huupponen R
    Br J Pharmacol; 1995 Aug; 115(7):1182-7. PubMed ID: 7582542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and drug distribution studies do not support direct inhibitory effects of metformin on intestinal glucose absorption.
    Cuber JC; Bosshard A; Vidal H; Vega F; Wiernsperger N; Rapin JR
    Diabete Metab; 1994; 20(6):532-9. PubMed ID: 7713276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of metformin on insulin resistance after injury in the rat.
    Frayn KN
    Diabetologia; 1976 Mar; 12(1):53-60. PubMed ID: 1254116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.